DE3481913D1
(de)
|
1983-04-27 |
1990-05-17 |
Ici America Inc |
Prolin-derivate.
|
FR2663336B1
(fr)
|
1990-06-18 |
1992-09-04 |
Adir |
Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
FR2713225B1
(fr)
|
1993-12-02 |
1996-03-01 |
Sanofi Sa |
N-pipéridino-3-pyrazolecarboxamide substitué.
|
US5631365A
(en)
|
1993-09-21 |
1997-05-20 |
Schering Corporation |
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
|
US5656624A
(en)
|
1994-12-21 |
1997-08-12 |
Schering Corporation |
4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
|
PT877750E
(pt)
|
1995-10-31 |
2002-09-30 |
Schering Corp |
2-azetidinonas substituidas por acucar uteis como agentes hipocolesterolemiantes
|
US6225310B1
(en)
|
1996-01-17 |
2001-05-01 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
WO1997026265A1
(en)
|
1996-01-17 |
1997-07-24 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
|
US5739321A
(en)
|
1996-05-31 |
1998-04-14 |
Schering Corporation |
3-hydroxy γ-lactone based enantionselective synthesis of azetidinones
|
DE122009000079I2
(de)
|
1996-08-30 |
2011-06-16 |
Novo Nordisk As Novo Alle |
Glp-1 derivate
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US5756470A
(en)
|
1996-10-29 |
1998-05-26 |
Schering Corporation |
Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
|
DK0958296T3
(da)
|
1996-12-31 |
2003-08-18 |
Reddys Lab Ltd Dr |
Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
KR20010021936A
(ko)
|
1997-07-16 |
2001-03-15 |
한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 |
융합된 1,2,4-티아디아진 유도체, 그의 제조와 사용
|
CO4970713A1
(es)
|
1997-09-19 |
2000-11-07 |
Sanofi Synthelabo |
Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
|
DE69917237T2
(de)
|
1998-03-12 |
2005-05-04 |
Teijin Ltd. |
Benzofurylpyron-derivate
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
DE19845405C2
(de)
|
1998-10-02 |
2000-07-13 |
Aventis Pharma Gmbh |
Arylsubstituierte Propanolaminderivate und deren Verwendung
|
CN1495198A
(zh)
|
1998-12-07 |
2004-05-12 |
�о���Ӧ�ÿ�ѧЭ��ɷ�����˾ |
胰高血糖素样肽-1的类似物
|
GB9900416D0
(en)
|
1999-01-08 |
1999-02-24 |
Alizyme Therapeutics Ltd |
Inhibitors
|
DE19916108C1
(de)
|
1999-04-09 |
2001-01-11 |
Aventis Pharma Gmbh |
Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
AU4343500A
(en)
|
1999-04-16 |
2000-11-02 |
Schering Corporation |
Use of azetidinone compounds
|
YU72201A
(sh)
|
1999-04-28 |
2005-07-19 |
Aventis Pharma Deutschland Gmbh. |
Derivati di-aril kiseline kao ppar receptorski ligandi
|
ES2261202T3
(es)
|
1999-04-28 |
2006-11-16 |
Sanofi-Aventis Deutschland Gmbh |
Derivados de acido de triarilo como ligandos para el receptor ppar.
|
GB9911863D0
(en)
|
1999-05-21 |
1999-07-21 |
Knoll Ag |
Therapeutic agents
|
CA2376919C
(en)
|
1999-06-18 |
2008-11-04 |
Merck & Co., Inc. |
Arylthiazolidinedione and aryloxazolidinedione derivatives
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
WO2001009111A1
(en)
|
1999-07-29 |
2001-02-08 |
Eli Lilly And Company |
Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists
|
EP1218341B1
(de)
|
1999-09-01 |
2005-08-24 |
Aventis Pharma Deutschland GmbH |
Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
PE20011010A1
(es)
|
1999-12-02 |
2001-10-18 |
Glaxo Group Ltd |
Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
|
EP1259246A2
(en)
|
2000-02-25 |
2002-11-27 |
Novo Nordisk A/S |
Use of dpp-iv inhibitors for the treatment of diabetes
|
AU5257401A
(en)
|
2000-04-28 |
2001-11-12 |
Asahi Chemical Ind |
Novel bicyclic compounds
|
EP1280777B1
(en)
|
2000-05-11 |
2005-11-23 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
ATE362468T1
(de)
|
2000-07-25 |
2007-06-15 |
Merck & Co Inc |
N-substituierte indole mit anwendung in der behandlung von diabetes
|
HUP0004741A2
(hu)
|
2000-11-28 |
2002-12-28 |
Sanofi-Synthelabo |
Kémiai eljárás tiazolszármazékok előállítására és új intermedier
|
AU2002216097B2
(en)
|
2000-12-21 |
2006-09-07 |
Sanofi-Aventis Deutschland Gmbh |
Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
|
IL156552A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
AU2002231688A1
(en)
|
2000-12-21 |
2002-07-01 |
Sanofi-Aventis Deutschland Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
TWI291957B
(en)
|
2001-02-23 |
2008-01-01 |
Kotobuki Pharmaceutical Co Ltd |
Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
|
GB0113233D0
(en)
|
2001-05-31 |
2001-07-25 |
Glaxo Group Ltd |
Chemical compounds
|
DE10139416A1
(de)
|
2001-08-17 |
2003-03-06 |
Aventis Pharma Gmbh |
Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US6884812B2
(en)
|
2001-08-31 |
2005-04-26 |
Aventis Pharma Deutschland Gmbh |
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
|
BR0212158A
(pt)
|
2001-08-31 |
2004-07-13 |
Aventis Pharma Gmbh |
Derivados de diarilcicloalquila, processos para a sua preparação e sua aplicação como ativadores de ppar
|
DE10215907A1
(de)
|
2002-04-11 |
2003-11-06 |
Aventis Pharma Gmbh |
Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
|
JPWO2003097064A1
(ja)
|
2002-05-17 |
2005-09-15 |
協和醗酵工業株式会社 |
糖尿病治療剤
|
DE10227508A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US7176193B2
(en)
|
2002-06-19 |
2007-02-13 |
Sanofi-Aventis Deutschland Gmbh |
Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
|
US7176194B2
(en)
|
2002-06-19 |
2007-02-13 |
Sanofi-Aventis Deutschland Gmbh |
Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
|
DE10227507A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US7671047B2
(en)
|
2002-06-19 |
2010-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
|
DE10227506A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
GB0215579D0
(en)
|
2002-07-05 |
2002-08-14 |
Astrazeneca Ab |
Chemical compounds
|
RS20050019A
(en)
|
2002-07-12 |
2007-09-21 |
Sanofi - Aventis Pharma Deutschland Gmbh., |
Heterocyclically substituted benzoylureas,method for their production and their use as medicaments
|
DE10314610A1
(de)
*
|
2003-04-01 |
2004-11-04 |
Aventis Pharma Deutschland Gmbh |
Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung
|
WO2004097655A1
(ja)
|
2003-04-25 |
2004-11-11 |
Matsushita Electric Industrial Co. Ltd. |
マルチメディア情報共有システム
|
JP2005015434A
(ja)
|
2003-06-27 |
2005-01-20 |
Kotobuki Seiyaku Kk |
血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
|
EP1644399A2
(en)
|
2003-07-09 |
2006-04-12 |
Forbes Medi-Tech Inc. |
Novel compounds and compositions comprising sterols and/or stanols and cholesterol biosynthesis inhibitors and use thereof in treating or preventing a variety of diseases and conditions.
|
WO2005005477A2
(en)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
WO2005021495A2
(en)
|
2003-08-25 |
2005-03-10 |
Microbia Inc. |
Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
|
US20070161577A1
(en)
|
2003-08-28 |
2007-07-12 |
Martinez Eduardo J |
Tethered dimers and trimers of 1,4-diphenylazetidin-2-ones
|
BRPI0414539B8
(pt)
|
2003-09-19 |
2021-05-25 |
Novo Nordisk As |
composto, composição farmacêutica, e, uso de um composto
|
EP1522541A1
(en)
|
2003-10-07 |
2005-04-13 |
Lipideon Biotechnology AG |
Novel hypocholesterolemic compounds
|
AU2004286838A1
(en)
|
2003-10-30 |
2005-05-19 |
Merck & Co., Inc. |
2-azetidinones as anti-hypercholesterolemic agents
|
WO2005042692A2
(en)
|
2003-10-31 |
2005-05-12 |
Forbes Medi-Tech Inc. |
A method of inhibiting the expression of genes which mediate cellular cholesterol influx in animal cells and inhibiting the production of proteins resulting from the expression of such genes using cholesterol absorption inhibitors
|
PT1682499E
(pt)
|
2003-11-10 |
2007-11-05 |
Microbia Inc |
4-biarilil-1-fenilazetidin-2-onas
|
GB0329778D0
(en)
|
2003-12-23 |
2004-01-28 |
Astrazeneca Ab |
Chemical compounds
|
AU2004308332B2
(en)
|
2003-12-23 |
2008-04-10 |
Merck Sharp & Dohme Corp. |
Anti-hypercholesterolemic compounds
|
AU2004303742B2
(en)
|
2003-12-23 |
2008-06-19 |
Astrazeneca Ab |
Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
|
JP2007517800A
(ja)
|
2004-01-06 |
2007-07-05 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
糖尿病および肥満を処置するためのグリコーゲンホスホリラーゼインヒビターとしての(3−オキソ−3,4−ジヒドロ−キノキサリン−2−イル−アミノ)−ベンズアミド誘導体および関連化合物
|
DE102004006325A1
(de)
|
2004-02-10 |
2005-08-25 |
Bayer Healthcare Ag |
Tetrahydrobenzo[d]azepin-2-on-Derivate und ihre Verwendung
|
CN1930143B
(zh)
|
2004-03-10 |
2012-04-04 |
詹森药业有限公司 |
具有微粒体甘油三酸酯传递蛋白质抑制活性的被五元杂环取代的芳基哌啶或哌嗪
|
WO2005097738A1
(ja)
|
2004-04-06 |
2005-10-20 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規スルホンアミド誘導体
|
WO2005097076A2
(en)
|
2004-04-09 |
2005-10-20 |
Smithkline Beecham Corporation |
Low dose pharmaceutical products
|
DE102004025072A1
(de)
|
2004-05-21 |
2005-12-15 |
Sanofi-Aventis Deutschland Gmbh |
Verfahren zur Herstellung von Diphenyl-azetidinon-Derivaten
|
FR2871463B1
(fr)
|
2004-06-11 |
2006-09-22 |
Merck Sante Soc Par Actions Si |
Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
|
JP2008504266A
(ja)
|
2004-06-24 |
2008-02-14 |
イーライ リリー アンド カンパニー |
異脂肪血症を治療するための化合物及び方法
|
WO2006017257A2
(en)
|
2004-07-12 |
2006-02-16 |
Phenomix Corporation |
Azetidinone derivatives
|
FR2873368B1
(fr)
|
2004-07-26 |
2008-01-04 |
Merck Sante Soc Par Actions Si |
Derives de guanidine et leurs utilisations en therapeutique
|
FR2873694B1
(fr)
|
2004-07-27 |
2006-12-08 |
Merck Sante Soc Par Actions Si |
Nouveaux aza-indoles inhibiteurs de la mtp et apob
|
WO2006029699A1
(en)
|
2004-09-11 |
2006-03-23 |
Sanofi-Aventis Deutschland Gmbh |
7-azaindoles and their use as ppar agonists
|
EP1799711B1
(en)
|
2004-10-07 |
2012-06-20 |
Novo Nordisk A/S |
Protracted exendin-4 compounds
|
WO2006037810A2
(en)
|
2004-10-07 |
2006-04-13 |
Novo Nordisk A/S |
Protracted glp-1 compounds
|
KR20070070231A
(ko)
|
2004-10-22 |
2007-07-03 |
스미스클라인 비참 코포레이션 |
Hm74a 수용체 활성을 가지는 크산틴 유도체
|
WO2006045564A1
(en)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Xanthine derivatives with hm74a receptor activity
|
JPWO2006059744A1
(ja)
|
2004-11-30 |
2008-06-05 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤活性化受容体δの活性化剤
|
JP2008524137A
(ja)
|
2004-12-18 |
2008-07-10 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
(5s)−3−[(s)−フルオロ(4−トリフルオロメチルフェニル)メチル−5,6,7,8−テトラヒドロキノリン−5−オール誘導体およびcetp阻害剤としてのそれらの使用
|
PE20060949A1
(es)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
Derivados fusionados de pirazol como agonistas del receptor de niacina
|
BRPI0516407A
(pt)
|
2004-12-24 |
2008-09-02 |
Prosidion Ltd |
agonistas de receptor acoplado à proteìna g (gpr116) e uso destes para o tratamento de obesidade e diabetes
|
JP5065908B2
(ja)
|
2004-12-24 |
2012-11-07 |
プロシディオン・リミテッド |
Gタンパク質結合受容体作動薬
|
WO2006073973A2
(en)
|
2004-12-31 |
2006-07-13 |
Reddy Us Therapeutics, Inc. |
Novel benzylamine derivatives as cetp inhibitors
|
DE102005000666B3
(de)
|
2005-01-04 |
2006-10-05 |
Sanofi-Aventis Deutschland Gmbh |
Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2006084176A2
(en)
|
2005-02-03 |
2006-08-10 |
Irm Llc |
Compounds and compositions as ppar modulators
|
US20090005321A1
(en)
|
2005-02-09 |
2009-01-01 |
Microbia, Inc. |
Phenylazetidinone Derivatives
|
FR2883000B1
(fr)
|
2005-03-14 |
2007-06-01 |
Merck Sante Soc Par Actions Si |
Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique
|
US20090186834A1
(en)
|
2005-03-24 |
2009-07-23 |
Microbia, Inc. |
Diphenylheterocycle cholesterol absorption inhibitors
|
CA2603757A1
(en)
|
2005-04-13 |
2006-10-26 |
Merck & Co., Inc. |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
EP1877067A1
(en)
|
2005-04-26 |
2008-01-16 |
Microbia, Inc. |
4-biarylyl-1-phenylazetidin-2-one glucuronide derivatives for hypercholesterolemia
|
US20090131395A1
(en)
|
2005-05-05 |
2009-05-21 |
Microbia, Inc. |
Biphenylazetidinone cholesterol absorption inhibitors
|
JP2008539735A
(ja)
|
2005-05-06 |
2008-11-20 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
グルカゴン様ペプチド1(glp−1)受容体アンタゴニストおよびそれらの薬理学的使用方法
|
WO2006122186A2
(en)
|
2005-05-10 |
2006-11-16 |
Microbia, Inc. |
1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
|
AU2006244043A1
(en)
|
2005-05-11 |
2006-11-16 |
Microbia, Inc. |
Processes for production of phenolic 4-biphenylylazetidin-2-ones
|
DE602006017202D1
(de)
|
2005-05-13 |
2010-11-11 |
Lilly Co Eli |
Pegylierte glp-1-verbindungen
|
US7723342B2
(en)
|
2005-05-17 |
2010-05-25 |
Schering Corporation |
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
|
AU2006249905A1
(en)
|
2005-05-25 |
2006-11-30 |
Microbia, Inc. |
Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
|
WO2006138163A2
(en)
|
2005-06-15 |
2006-12-28 |
Merck & Co., Inc. |
Anti-hypercholesterolemic compounds
|
UY29607A1
(es)
|
2005-06-20 |
2007-01-31 |
Astrazeneca Ab |
Compuestos quimicos
|
AR054482A1
(es)
|
2005-06-22 |
2007-06-27 |
Astrazeneca Ab |
Derivados de azetidinona para el tratamiento de hiperlipidemias
|
AR057072A1
(es)
|
2005-06-22 |
2007-11-14 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR057383A1
(es)
|
2005-06-22 |
2007-12-05 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR057380A1
(es)
|
2005-06-22 |
2007-11-28 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
|
SA06270191B1
(ar)
|
2005-06-22 |
2010-03-29 |
استرازينيكا ايه بي |
مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
|
AR056866A1
(es)
|
2005-06-22 |
2007-10-31 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, una formulacion farmaceutica y un proceso de preparacion del compuesto
|
US7067689B1
(en)
*
|
2005-07-08 |
2006-06-27 |
Microbia, Inc. |
Process for production of pentahydroxyhexylcarbamoyl alkanoic acids
|
JP2007022943A
(ja)
|
2005-07-13 |
2007-02-01 |
Dai Ichi Seiyaku Co Ltd |
スクアレン合成酵素阻害薬
|
DE102005033100B3
(de)
|
2005-07-15 |
2007-01-25 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung
|
DE102005033099A1
(de)
|
2005-07-15 |
2007-01-18 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung
|
WO2007015744A1
(en)
|
2005-07-21 |
2007-02-08 |
Incyte Corporation |
Disubstituted thienyl compounds and their use as pharmaceuticals
|
AR055369A1
(es)
|
2005-08-10 |
2007-08-22 |
Smithkline Beecham Corp |
Compuestos derivados de xantina, su uso para preparar un medicamento para el tratamiento de una enfermedad mediada por el receptor hm74a, formulaciones y combinacion farmaceuticas que la comprenden y metodo de preparacion de los mismos
|
GB0516462D0
(en)
|
2005-08-10 |
2005-09-14 |
Smithkline Beecham Corp |
Novel compounds
|
US20090258862A1
(en)
|
2005-08-29 |
2009-10-15 |
Colletti Steven L |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
KR20080040046A
(ko)
|
2005-08-31 |
2008-05-07 |
아스텔라스세이야쿠 가부시키가이샤 |
티아졸 유도체
|
CA2624093A1
(en)
|
2005-09-29 |
2007-04-12 |
Sanofi-Aventis |
Phenyl- and pyridyl-i,2,4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
|
WO2007041494A2
(en)
|
2005-09-30 |
2007-04-12 |
Merck & Co., Inc. |
Cholesteryl ester transfer protein inhibitors
|
DE102005055726A1
(de)
*
|
2005-11-23 |
2007-08-30 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US20080319218A1
(en)
|
2007-06-22 |
2008-12-25 |
Andreas Haubrich |
Processes for Making and Using Benzyl Pentahydroxyhexylcarbamoylundecanoate
|
US20080319221A1
(en)
|
2007-06-22 |
2008-12-25 |
Bernd Junker |
Esters of Pentahydroxyhexylcarbamoyl Alkanoic Acids
|
WO2009112203A1
(de)
*
|
2008-03-14 |
2009-09-17 |
Sanofi-Aventis Deutschland Gmbh |
Verfahren zur herstellung eines diphenylazetidinons
|